• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱法测定马炎性渗出液和血浆中氟尼辛的含量。

Measurement of flunixin in equine inflammatory exudate and plasma by high performance liquid chromatography.

作者信息

Higgins A J, Lees P, Sharma S C, Taylor J B

出版信息

Equine Vet J. 1987 Jul;19(4):303-6. doi: 10.1111/j.2042-3306.1987.tb01416.x.

DOI:10.1111/j.2042-3306.1987.tb01416.x
PMID:3497803
Abstract

An accurate and reliable method for the separation of flunixin from, and measurement in, equine inflammatory exudate and plasma by high performance liquid chromatography has been developed. Flunixin can be detected in concentrations as low as 0.05 micrograms/ml using an ultraviolet spectrophotometric detector at 285 nm. Samples were acidified with 2M hydrochloric acid and extracted with dichloromethane. The extract was evaporated and reconstituted in acetonitrile. Iminodibenzyl was used as internal standard. The mean recovery of flunixin from plasma was 97.6 +/- 3.9 per cent. Particular advantages of the method are the short analysis time and ease of sample preparation. Data were obtained on the distribution of flunixin between plasma and acute inflammatory exudate following administration of a single intravenous dose of 1.1 mg/kg bodyweight flunixin meglumine. The drug was cleared more slowly from exudate than from plasma.

摘要

已开发出一种通过高效液相色谱法从马炎性渗出液和血浆中分离氟尼辛并进行测定的准确可靠方法。使用285nm的紫外分光光度检测器,氟尼辛的检测浓度可低至0.05微克/毫升。样品用2M盐酸酸化,并用二氯甲烷萃取。萃取液蒸发后用乙腈复溶。亚氨基二苄用作内标。氟尼辛从血浆中的平均回收率为97.6±3.9%。该方法的特别优点是分析时间短且样品制备容易。在静脉注射1.1mg/kg体重的氟尼辛葡甲胺单次剂量后,获得了氟尼辛在血浆和急性炎性渗出液之间分布的数据。该药物从渗出液中的清除比从血浆中更慢。

相似文献

1
Measurement of flunixin in equine inflammatory exudate and plasma by high performance liquid chromatography.高效液相色谱法测定马炎性渗出液和血浆中氟尼辛的含量。
Equine Vet J. 1987 Jul;19(4):303-6. doi: 10.1111/j.2042-3306.1987.tb01416.x.
2
Flunixin meglumine: quantitative determination in and effects on composition of equine inflammatory exudate.
Br Vet J. 1986 Mar-Apr;142(2):163-9. doi: 10.1016/0007-1935(86)90093-X.
3
Identification of a flunixin metabolite in the horse by gas chromatography-mass spectrometry.
J Chromatogr. 1987 Dec 25;423:123-30. doi: 10.1016/0378-4347(87)80334-1.
4
Flunixin inhibits prostaglandin E2 production in equine inflammation.氟尼辛可抑制马炎症中前列腺素E2的产生。
Res Vet Sci. 1984 Nov;37(3):347-9.
5
Evaluation of flunixin meglumine pour-on administration on prostaglandin E concentration in inflammatory exudate after induction of inflammation in cattle.氟尼辛葡甲胺浇泼剂对牛炎症诱导后炎性渗出物中前列腺素E浓度影响的评估
Res Vet Sci. 2017 Oct;114:294-296. doi: 10.1016/j.rvsc.2017.04.010. Epub 2017 Apr 20.
6
[Flunixin and its use in horses].[氟尼辛及其在马匹中的应用]
Ann Rech Vet. 1986;17(4):353-62.
7
Quantification and confirmation of flunixin in equine plasma by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry.采用液相色谱-四极杆飞行时间串联质谱法对马血浆中的氟尼辛进行定量和确证。
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 5;801(2):173-84. doi: 10.1016/j.jchromb.2003.11.002.
8
Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
J Vet Pharmacol Ther. 1998 Aug;21(4):315-21. doi: 10.1046/j.1365-2885.1998.00144.x.
9
Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.氟罗昔康或氟尼辛葡甲胺对缺血性损伤马空肠恢复的影响。
Am J Vet Res. 2009 Aug;70(8):992-1000. doi: 10.2460/ajvr.70.8.992.
10
Distribution of flunixin meglumine and firocoxib into aqueous humor of horses.氟尼辛葡甲胺和非甾体类抗炎药(昔布类)在马房水中的分布。
J Vet Intern Med. 2011 Sep-Oct;25(5):1127-33. doi: 10.1111/j.1939-1676.2011.0763.x. Epub 2011 Jul 22.

引用本文的文献

1
Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits.氟尼辛在健康和内毒素血症兔静脉注射后的药代动力学
Vet Res Commun. 2006 Jan;30(1):73-81. doi: 10.1007/s11259-005-3227-7.